BeyondSpring Inc. (BYSI) vs Kyntra Bio Inc (KYNB)

BeyondSpring Inc. and Kyntra Bio Inc are both Biotechnology companies. BeyondSpring Inc. and Kyntra Bio Inc are of similar size ($29.8M and $28.3M). BeyondSpring Inc. has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.2×. Kyntra Bio Inc has the higher net margin (3,967.8% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Kyntra Bio Inc leads on 7 and BeyondSpring Inc. on 6.

Valuation

Metric BYSI KYNB Biotechnology median
P/E n/m 0.15 7.88
P/S 23.74 6.08 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 21.16 18.18 10.73
Earnings yield (33.71%) 652.74% (28.84%)
Free cash flow yield (52.37%) (135.59%) (23.03%)

Profitability

Metric BYSI KYNB Biotechnology median
Gross margin 100.00% 6.28% 65.16%
Operating margin 0.00% (1,089.78%) 0.00%
Net margin 0.00% 3,967.77% 0.00%
Free cash flow margin 0.00% (824.19%) 0.00%
Return on equity 24.96% (157.83%) (57.72%)
Return on assets (29.29%) 131.26% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BYSI KYNB Biotechnology median
Revenue growth (TTM) — (37.15%) 5.64%
EPS growth (last fiscal year) 96.30% 478.08% —
Revenue growth, 5-year CAGR — (48.42%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BYSI KYNB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.70 2.69 4.73
Net debt to EBITDA 1.42 1.97 0.96

Dividend

Metric BYSI KYNB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BYSI KYNB Biotechnology median
Market cap 29.81m 28.34m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack